Ocuphire Pharma (NASDAQ:OCUP) just reported results for the first quarter of 2024.
- Ocuphire Pharma reported earnings per share of -29 cents. This was below the analyst estimate for EPS of -13 cents.
- The company reported revenue of $1.71 million.
- This was 59.74% worse than the analyst estimate for revenue of $4.25 million.